The Journal of Urology
Volume 179, Issue 2 , Pages 748-753 , February 2008

Selective Prostate Cancer Thermal Ablation With Laser Activated Gold Nanoshells

Received 25 April 2007

References 

  1. Carroll PR, Presti JC, Small E, Roach M. Focal therapy for prostate cancer 1996: maximizing outcome. Urology. 1997;49:84
  2. Akduman B, Barqawi AB, Crawford ED. Minimally invasive surgery in prostate cancer: current and future perspectives. Cancer J. 2005;11:355
  3. Uchida T, Ohkusa H, Yamashita H, Shoji S, Nagata Y, Hyodo T, et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol. 2006;13:228
  4. Hacker A, Kohrmann KU, Back W, Kraut O, Marlinghaus E, Alken P, et al. Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int. 2005;96:71
  5. Beerlage HP, Thuroff S, Debruyne FM, Chaussy C, de la Rosette JJ. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology. 1999;54:273
  6. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 2005;5:709
  7. Hirsch LR, Gobin AM, Lowery AR, Tam F, Drezek RA, Halas NJ, et al. Metal nanoshells. Ann Biomed Eng. 2006;34:15
  8. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A. 2003;100:13549
  9. O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209:171
  10. Stern JM, Anderson JK, Lotan Y, Park S, Cadeddu JA. Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure?. J Urol. 2006;176:1969
  11. Litzinger DC, Buiting AM, van Rooijen N, Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta. 1994;1190:99
  12. Stern JM, Stanfield J, Lotan Y, Park S, Hsieh JT, Cadeddu JA. The efficacy of laser activated gold nanoshells to ablate prostate cancer cells in vitro. J Endourol. 2007;21:939
  13. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 1994;54:3352
  14. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000;60:6950
  15. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res. 2000;60:4440
  16. Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, et al. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi’s sarcoma. J Clin Pharmacol. 1996;36:55
  17. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol. 2004;22:969
  18. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A. 2006;103:6315
  19. Patriarca C, Bergamaschi F, Gazzano G, Corrada P, Ordesi G, Zanitzer L, et al. Histopathological findings after radiofrequency (RITA) treatment for prostate cancer. Prostate Cancer Prostatic Dis. 2006;9:266
  20. Mambula SS, Calderwood SK. Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. Int J Hyperthermia. 2006;22:575

 Supported by the Department of Urology, University of Texas Southwestern Medical Center.

PII: S0022-5347(07)02489-5

doi: 10.1016/j.juro.2007.09.018

The Journal of Urology
Volume 179, Issue 2 , Pages 748-753 , February 2008